Venturi Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
LMFP
FWIA
DLA
AAMU
ORIO
CNB
UBP
Venturi Wealth Management's BMY Position: Q2 2026 in Review
Venturi Wealth Management increased its Bristol-Myers Squibb (BMY) stake by 26% in Q2 2026, buying an estimated $90.6K and bringing the position to 7,650 shares worth $441K. The position accounts for 0.02% of the portfolio, ranked #411.
Venturi Wealth Management first reported a position in BMY in Q1 2020 and has held it in 16 quarters since. The position peaked at $510K in Q2 2020. 500 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Venturi Wealth Management held 7,650 shares of Bristol-Myers Squibb worth $441K as of Q2 2026.
- Venturi Wealth Management bought 1,578 Bristol-Myers Squibb shares in Q2 2026, an estimated $90.6K.
- Bristol-Myers Squibb made up 0.02% of Venturi Wealth Management's portfolio in Q2 2026, its #411 holding.
- Venturi Wealth Management first reported a position in Bristol-Myers Squibb in Q1 2020 and has held it in 16 quarters since.
- Venturi Wealth Management's Bristol-Myers Squibb position peaked at $510K in Q2 2020.
- 500 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Venturi Wealth Management's 13F filing for Q2 2026, filed 20 Jul 2026.